Catalyst Wire Dossier Catalyst Wire Dossier

REGN17092

· Regeneron Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for REGN17092, covering 2025-03-27 to 2025-03-27. Get the full timeline:

Most recent: Clinical Trial Update: A Trial to Learn if Different Doses of REGN17092 Are Safe in Healthy Adults [Phase 1]

See pricing